PureTech Health LLC 4
4 · GELESIS HOLDINGS, INC. · Filed May 3, 2023
Insider Transaction Report
Form 4
GELESIS HOLDINGS, INC.NYSE: GLS
PureTech Health plc
10% Owner
Transactions
- Purchase
Convertible Note
2023-05-01$5000000.00/sh+5,000,000$25,000,000,000,000→ 5,000,000 total(indirect: By LLC)Exercise: $0.27From: 2023-05-01Exp: 2023-07-31→ Common Stock (18,634,597 underlying) - Purchase
Convertible Note
2023-05-01$2000000.00/sh+2,000,000$4,000,000,000,000→ 2,000,000 total(indirect: By LLC)Exercise: $0.02From: 2023-05-01Exp: 2023-07-31→ Common Stock (109,890,110 underlying) - Purchase
Warrants
2023-05-01+23,688,047→ 23,688,047 total(indirect: By LLC)Exercise: $0.27From: 2023-05-01Exp: 2028-02-21→ Common Stock (23,688,047 underlying) - Purchase
Warrants
2023-05-01+192,307,692→ 192,307,692 total(indirect: By LLC)Exercise: $0.02From: 2023-05-01Exp: 2028-05-01→ Common Stock (192,307,692 underlying)
Footnotes (3)
- [F1]Pursuant to a Note and Warrant Purchase Agreement, on February 21, 2023, the Issuer issued to PureTechHealth LLC convertible notes in an aggregate principal amount of $5,000,000 as well as warrants to purchase 23,688,047 shares of common stock. At the time of issuance, both the conversion of the convertible notes and exercise of the warrants was subject to the Issuer first receiving stockholder approval for the issuance of the underlying shares of common stock. On May 1, 2023, the Issuer and the Reporting Persons amended the terms of the convertible notes and warrants to remove this restriction on conversion and exercise, respectively.
- [F2]The number of shares underlying the convertible notes reported herein is based on the outstanding principal amount plus accrued and unpaid interest as of April 30, 2023, and such number is subject to adjustment in accordance with the terms of the convertible notes.
- [F3]The warrants were issued in connection with the purchase of the convertible note purchases reported herein